Canara HSBC Life Insurance Company Ltd (CANHLIFE) Q1 FY27 Results Analysis: Solvency Rises to 198%, Expense Ratio Climbs to 20.7%
Canara HSBC Life Insurance Company Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 2,161.06 Cr (+23.70% YoY) and PAT growth of +20.20% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | July 20, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 2,161.06 Cr (+23.70% YoY) |
| PAT (Q1) | Rs. 28.14 Cr (+20.20% YoY) |
| EPS (Q1) | Rs. 0.30 (+20.00% YoY) |
| Market cap | Rs. 14,269.00 Cr |
| CMP | Rs. 150.20 |
Quarter Snapshot
Canara HSBC Life Insurance delivered strong YoY growth in premiums and PAT, with solvency improving to 198%. However, expense management ratio rose to 20.7% and persistency softened, while the product mix shift toward traditional products is a positive for margins. The company's growth lagged the industry, indicating potential market share loss.
Key Investment Insights
Key Positives
- Gross premium grew 23.7% YoY to Rs.2,161 Cr.
- PAT grew 20.2% YoY to Rs.28.14 Cr.
- Solvency ratio improved to 198% from 190% QoQ.
- Product mix shifted toward traditional products (65.4% vs 61.2% YoY), supporting VNB margins.
- Linked NP Life segment surplus swung to Rs.2,734 Lakhs from Rs.990 Lakhs YoY.
- Shareholders' GNPA declined to 4.5% from 5.4% YoY.
- No investor complaints received during the quarter.
Risk Factors
- Expense of management ratio rose to 20.7% from 19.6% YoY, outpacing premium growth.
- 13-month persistency declined to 81.8% from 82.5% YoY.
- Gross premium growth (23.7% YoY) lagged industry NBP growth of 39% YoY, indicating potential market share loss.
- Current ratio dropped to 1.03x from 1.36x, indicating tighter liquidity.
- Contingent liabilities increased to Rs.345.8 Cr from Rs.319.9 Cr YoY.
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.